Endometrial polyps and associated factors in Danish women aged 36-74 years

American Journal of Obstetrics and Gynecology

Volumn 200, Issue 2, 2009, Pages 147.e1-147.e6

  Dreisler, Eva ^a   Sorensen, Soren Stampe ^a   Lose, Gunnar ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

associated factors; endometrial polyps; uterine polyps

Indexed keywords

DESOGESTREL; ETONOGESTREL; GESTAGEN; GESTODENE; LEVONORGESTREL; NORGESTIMATE; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; ENDOMETRIUM POLYP; FEMALE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; MENORRHAGIA; PRIORITY JOURNAL; QUESTIONNAIRE; SPONTANEOUS ABORTION;

EID: 58749108644     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2008.08.065     Document Type: Article

References (36)

1. Dreisler E., Stampe Sorensen S., Ibsen P.H., and Lose G. Prevalence of endometrial polyps and abnormal uterine bleeding in a Danish population aged 20-74 years. Ultrasound Obstet Gynecol (2008) In press
2. Peterson W.F., and Novak E.R. Endometrial polyps. Obstet Gynecol 8 (1956) 40-49
3. Lopes R.G., Baracat E.C., Albuquerque Neto L.C., et al. Analysis of estrogen- and progesterone-receptor expression in endometrial polyps. J Minim Invasive Gynecol 14 (2007) 300-303
4. Sant'Ana de Almeida E.C., Nogueira A.A., Candido dos Reis F.J., Zambelli Ramalho L.N., and Zucoloto S. Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps and adjacent endometrium in postmenopausal women. Maturitas 49 (2004) 229-233
5. Taylor L.J., Jackson T.L., Reid J.G., and Duffy S.R. The differential expression of oestrogen receptors, progesterone receptors, Bcl-2 and Ki67 in endometrial polyps. BJOG 110 (2003) 794-798
6. McGurgan P., Taylor L.J., Duffy S.R., and O'Donovan P.J. Are endometrial polyps from pre-menopausal women similar to post-menopausal women?. An immunohistochemical comparison of endometrial polyps from pre- and post-menopausal women. Maturitas 54 (2006) 277-284
7. Dal Cin P., De Wolf F., Klerckx P., and Van Den Berghe H. The 6p21 chromosome region is nonrandomly involved in endometrial polyps. Gynecol Oncol 46 (1992) 393-396
8. Vanni R., Dal Cin P., Marras S., et al. Endometrial polyp: another benign tumor characterized by 12q13-q15 changes. Cancer Genet Cytogenet 68 (1993) 32-33
9. Inceboz U.S., Nese N., Uyar Y., et al. Hormone receptor expressions and proliferation markers in postmenopausal endometrial polyps. Gynecol Obstet Invest 61 (2006) 24-28
10. Orvieto R., Bar-Hava I., Dicker D., Bar J., Ben Rafael Z., and Neri A. Endometrial polyps during menopause: characterization and significance. Acta Obstet Gynecol Scand 78 (1999) 883-886
11. Savelli L., De Iaco P., Santini D., et al. Histopathologic features and risk factors for benignity, hyperplasia, and cancer in endometrial polyps. Am J Obstet Gynecol 188 (2003) 927-931
12. Ben Arie A., Goldchmit C., Laviv Y., et al. The malignant potential of endometrial polyps. Eur J Obstet Gynecol Reprod Biol 115 (2004) 206-210
13. Anastasiadis P.G., Skaphida P.G., Koutlaki N.G., Galazios G.C., Tsikouras P.N., and Liberis V.A. Descriptive epidemiology of endometrial hyperplasia in patients with abnormal uterine bleeding. Eur J Gynaecol Oncol 21 (2000) 131-134
14. Shushan A., Revel A., and Rojansky N. How often are endometrial polyps malignant?. Gynecol Obstet Invest 58 (2004) 212-215
15. DeWaay D.J., Syrop C.H., Nygaard I.E., Davis W.A., and Van Voorhis B.J. Natural history of uterine polyps and leiomyomata. Obstet Gynecol 100 (2002) 3-7
16. Reslova T., Tosner J., Resl M., Kugler R., and Vavrova I. Endometrial polyps: a clinical study of 245 cases. Arch Gynecol Obstet 262 (1999) 133-139
17. Coeman D., Van Belle Y., Vanderick G., De Muylder X., De Muylder E., and Campo R. Hysteroscopic findings in patients with a cervical polyp. Am J Obstet Gynecol 169 (1993) 1563-1565
18. Vilodre L.C., Bertat R., Petters R., and Reis F.M. Cervical polyp as risk factor for hysteroscopically diagnosed endometrial polyps. Gynecol Obstet Invest 44 (1997) 191-195
19. Maia Jr. H., Barbosa I.C., Marques D., Calmon L.C., Ladipo O.A., and Coutinho E.M. Hysteroscopy and transvaginal sonography in menopausal women receiving hormone replacement therapy. J Am Assoc Gynecol Laparosc 4 (1996) 13-18
20. Bakour S.H., Gupta J.K., and Khan K.S. Risk factors associated with endometrial polyps in abnormal uterine bleeding. Int J Gynaecol Obstet 76 (2002) 165-168
21. Perrone G., DeAngelis C., Critelli C., et al. Hysteroscopic findings in postmenopausal abnormal uterine bleeding: a comparison between HRT users and non-users. Maturitas 43 (2002) 251-255
22. Van den Bosch T., Van Schoubroeck D., Ameye L., De Brabanter J., van Huffel S., and Timmerman D. Ultrasound assessment of endometrial thickness and endometrial polyps in women on hormonal replacement therapy. Am J Obstet Gynecol 188 (2003) 1249-1253
23. Elliott J., Connor M.E., and Lashen H. The value of outpatient hysteroscopy in diagnosing endometrial pathology in postmenopausal women with and without hormone replacement therapy. Acta Obstet Gynecol Scand 82 (2003) 1112-1119
24. Oguz S., Sargin A., Kelekci S., Aytan H., Tapisiz O.L., and Mollamahmutoglu L. The role of hormone replacement therapy in endometrial polyp formation. Maturitas 50 (2005) 231-236
25. Maia Jr. H., Maltez A., Studard E., Athayde C., and Coutinho E.M. Effect of previous hormone replacement therapy on endometrial polyps during menopause. Gynecol Endocrinol 18 (2004) 299-304
26. Iatrakis G., Zervoudis S., Antoniou E., et al. Is dosage of hormone replacement therapy related with endometrial polyp formation?. Eur J Gynaecol Oncol 27 (2006) 393-394
27. World Health Organization classification of tumours. In: Tavassoli F.A., and Devilee P. (Eds). Pathology and genetics of tumours of the breast and female genital organs (2003), World Health Organization, Geneva 218-230
28. Ruta D.A., Garratt A.M., Chadha Y.C., Flett G.M., Hall M.H., and Russell I.T. Assessment of patients with menorrhagia: how valid is a structured clinical history as a measure of health status?. Qual Life Res 4 (1995) 33-40
29. Jorgensen T., Borch-Johnsen K., Thomsen T.F., Ibsen H., Glumer C., and Pisinger C. A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. Eur J Cardiovasc Prev Rehabil 10 (2003) 377-386
30. Pedersen A.T. Hormone replacement therapy and risk of stroke (1997), University of Copenhagen, Copenhagen [PhD thesis]
31. Landis J.R., and Koch G.G. The measurement of observer agreement for categorical data. Biometrics 33 (1977) 159-174
32. Onalan R., Onalan G., Tonguc E., Ozdener T., Dogan M., and Mollamahmutoglu L. Body mass index is an independent risk factor for the development of endometrial polyps in patients undergoing in vitro fertilization. Fertil Steril (2008) Epub ahead of print
33. Kedar R.P., Bourne T.H., Powles T.J., et al. Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet 343 (1994) 1318-1321
34. Cohen I. Endometrial pathologies associated with postmenopausal tamoxifen treatment. Gynecol Oncol 94 (2004) 256-266
35. Chalas E., Costantino J.P., Wickerham D.L., et al. Benign gynecologic conditions among participants in the Breast Cancer Prevention Trial. Am J Obstet Gynecol 192 (2005) 1230-1237
36. Perez-Medina T., Bajo-Arenas J., Haya J., et al. Tibolone and risk of endometrial polyps: a prospective, comparative study with hormone therapy. Menopause 10 (2003) 534-537